Literature DB >> 7156281

Plasma haloperidol levels and clinical response in acute schizophrenia.

I Extein, K A Augusthy, M S Gold, A L Pottash, D Martin, W Z Potter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7156281

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  6 in total

Review 1.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 2.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

3.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 4.  The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness.

Authors:  R Miller
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.

Authors:  A E Balant-Gorgia; R Eisele; L Balant; G Garrone
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

6.  Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice.

Authors:  L B Hansen; N E Larsen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.